IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v463y2010i7281d10.1038_nature08727.html
   My bibliography  Save this article

A new highly penetrant form of obesity due to deletions on chromosome 16p11.2

Author

Listed:
  • R. G. Walters

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.
    Imperial College London, London W2 1PG, UK.)

  • S. Jacquemont

    (Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • A. Valsesia

    (Departement de Génétique Médicale, Université de Lausanne, CH-1015 Lausanne, Switzerland.
    Ludwig Institute for Cancer Research, Université de Lausanne, CH-1015 Lausanne, Switzerland.
    Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.)

  • A. J. de Smith

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)

  • D. Martinet

    (Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • J. Andersson

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)

  • M. Falchi

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)

  • F. Chen

    (Brain Mind Institute, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.)

  • J. Andrieux

    (Laboratoire de Génétique Médicale, Centre Hospitalier Régional Universitaire, 59000 Lille, France.)

  • S. Lobbens

    (CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)

  • B. Delobel

    (Centre de Génétique Chromosomique, Hôpital Saint-Vincent de Paul, GHICL, 59020 Lille, France.)

  • F. Stutzmann

    (CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)

  • J. S. El-Sayed Moustafa

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)

  • J.-C. Chèvre

    (CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)

  • C. Lecoeur

    (CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)

  • V. Vatin

    (CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)

  • S. Bouquillon

    (Laboratoire de Génétique Médicale, Centre Hospitalier Régional Universitaire, 59000 Lille, France.)

  • J. L. Buxton

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)

  • O. Boute

    (Service de Génétique Clinique, Hôpital Jeanne de Flandre, Centre Hospitalier Universitaire de Lille, 59000 Lille, France.)

  • M. Holder-Espinasse

    (Service de Génétique Clinique, Hôpital Jeanne de Flandre, Centre Hospitalier Universitaire de Lille, 59000 Lille, France.)

  • J.-M. Cuisset

    (Service de Neuropédiatrie, Centre Hospitalier Régional Universitaire, 59000 Lille, France.)

  • M.-P. Lemaitre

    (Service de Neuropédiatrie, Centre Hospitalier Régional Universitaire, 59000 Lille, France.)

  • A.-E. Ambresin

    (Unité Multidisciplinaire de Santé des Adolescents, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • A. Brioschi

    (Service de Neuropsychologie et de Neuroréhabilitation, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • M. Gaillard

    (Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • V. Giusti

    (Service d’Endocrinologie, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • F. Fellmann

    (Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • A. Ferrarini

    (Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • N. Hadjikhani

    (Brain Mind Institute, École Polytechnique Fédérale de Lausanne, CH-1015 Lausanne, Switzerland.
    Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown, Massachusetts 02129, USA.)

  • D. Campion

    (INSERM, U614, Faculté de Médecine, 76183 Rouen, France.)

  • A. Guilmatre

    (INSERM, U614, Faculté de Médecine, 76183 Rouen, France.)

  • A. Goldenberg

    (Service de Génétique, Centre Hospitalier Universitaire de Rouen, 76031 Rouen, France.)

  • N. Calmels

    (Laboratoire de Diagnostic Génétique, Nouvel Hôpital civil, 67091 Strasbourg, France.)

  • J.-L. Mandel

    (Laboratoire de Diagnostic Génétique, Nouvel Hôpital civil, 67091 Strasbourg, France.)

  • C. Le Caignec

    (Centre Hospitalier Universitaire Nantes, Service de Génétique Médicale, 44093 Nantes, France.
    INSERM, UMR915, L’Institut du Thorax, 44007 Nantes, France.)

  • A. David

    (Centre Hospitalier Universitaire Nantes, Service de Génétique Médicale, 44093 Nantes, France.)

  • B. Isidor

    (Centre Hospitalier Universitaire Nantes, Service de Génétique Médicale, 44093 Nantes, France.)

  • M.-P. Cordier

    (Service de Génétique, Hospices Civils de Lyon, Hôpital de l’Hotel Dieu, 69288 Lyon, France.)

  • S. Dupuis-Girod

    (Service de Génétique, Hospices Civils de Lyon, Hôpital de l’Hotel Dieu, 69288 Lyon, France.)

  • A. Labalme

    (Service de Génétique, Hospices Civils de Lyon, Hôpital de l’Hotel Dieu, 69288 Lyon, France.)

  • D. Sanlaville

    (Service de Génétique, Hospices Civils de Lyon, Hôpital de l’Hotel Dieu, 69288 Lyon, France.
    EA 4171, Université Claude Bernard, 69622 Lyon, France.)

  • M. Béri-Dexheimer

    (Laboratoire de Génétique, Centre Hospitalier Universitaire, Nancy Université, 54511 Vandoeuvre les Nancy, France.)

  • P. Jonveaux

    (Laboratoire de Génétique, Centre Hospitalier Universitaire, Nancy Université, 54511 Vandoeuvre les Nancy, France.)

  • B. Leheup

    (Laboratoire de Génétique, Centre Hospitalier Universitaire, Nancy Université, 54511 Vandoeuvre les Nancy, France.
    EA4368 Medical School Nancy, Université Henri Poincaré, 54003 Nancy, France.)

  • K. Õunap

    (United Laboratories, Tartu University Children’s Hospital, 50406 Tartu, Estonia.)

  • E. G. Bochukova

    (University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)

  • E. Henning

    (University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)

  • J. Keogh

    (University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)

  • R. J. Ellis

    (North West Thames Regional Genetics Service, Northwick Park & St Marks Hospital, Harrow HA1 3UJ, UK.)

  • K. D. MacDermot

    (North West Thames Regional Genetics Service, Northwick Park & St Marks Hospital, Harrow HA1 3UJ, UK.)

  • M. M. van Haelst

    (North West Thames Regional Genetics Service, Northwick Park & St Marks Hospital, Harrow HA1 3UJ, UK.
    †Present address: Department of Medical Genetics, University Medical Centre Utrecht, 3584 EA Utrecht, The Netherlands.)

  • C. Vincent-Delorme

    (Centre Hospitalier D’Arras, Génétique Médicale, 62000 Arras, France.)

  • G. Plessis

    (Service de Génétique Médicale, Centre Hospitalier Universitaire Clemenceau, 14033 Caen, France.)

  • R. Touraine

    (Centre Hospitalier Universitaire–Hôpital Nord, Service de Génétique, 42055 Saint Étienne, France.)

  • A. Philippe

    (Université Paris Descartes, Hôpital Necker-Enfants Malades, 75015 Paris, France.)

  • V. Malan

    (Université Paris Descartes, Hôpital Necker-Enfants Malades, 75015 Paris, France.)

  • M. Mathieu-Dramard

    (Service de Génétique Clinique, Centre Hospitalier Universitaire, 80054 Amiens, France.)

  • J. Chiesa

    (Laboratoire de Cytogénétique, Centre Hospitalier Universitaire Caremeau, 30029 Nîmes, France.)

  • B. Blaumeiser

    (University Hospital & University of Antwerp, 2650 Edegem, Belgium.)

  • R. F. Kooy

    (University Hospital & University of Antwerp, 2650 Edegem, Belgium.)

  • R. Caiazzo

    (INSERM U859, Biotherapies for Diabetes, 59045 Lille, France.
    Université Lille Nord de France, Centre Hospitalier Universitaire Lille, 59037 Lille, France.)

  • M. Pigeyre

    (Université Lille Nord de France, Centre Hospitalier Universitaire Lille, 59037 Lille, France.)

  • B. Balkau

    (INSERM U780-IFR69, 94807 Villejuif, France.)

  • R. Sladek

    (McGill University and Genome Quebec Innovation Centre, Montreal H3A 1A4, Canada.
    McGill University, Montreal H3A 1B1, Canada.)

  • S. Bergmann

    (Departement de Génétique Médicale, Université de Lausanne, CH-1015 Lausanne, Switzerland.
    Swiss Institute of Bioinformatics, CH-1015 Lausanne, Switzerland.)

  • V. Mooser

    (GlaxoSmithKline, Philadelphia, Pennsylvania 19101, USA.)

  • D. Waterworth

    (GlaxoSmithKline, Philadelphia, Pennsylvania 19101, USA.)

  • A. Reymond

    (The Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne, Switzerland.)

  • P. Vollenweider

    (Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • G. Waeber

    (Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.)

  • A. Kurg

    (Institute of Molecular and Cell Biology, University of Tartu, 51010 Tartu, Estonia.)

  • P. Palta

    (Institute of Molecular and Cell Biology, University of Tartu, 51010 Tartu, Estonia.)

  • T. Esko

    (Estonian Genome Project, University of Tartu, 50410 Tartu, Estonia.
    Estonian Biocentre, 51010 Tartu, Estonia.)

  • A. Metspalu

    (Estonian Genome Project, University of Tartu, 50410 Tartu, Estonia.
    Estonian Biocentre, 51010 Tartu, Estonia.)

  • M. Nelis

    (Estonian Genome Project, University of Tartu, 50410 Tartu, Estonia.
    Estonian Biocentre, 51010 Tartu, Estonia.)

  • P. Elliott

    (Imperial College London, London W2 1PG, UK.)

  • A.-L. Hartikainen

    (University of Oulu, 90220 Oulu, Finland.)

  • M. I. McCarthy

    (Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Oxford OX3 7LJ, UK.
    Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford OX3 7BN, UK.)

  • L. Peltonen

    (Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.
    Institute of Molecular Medicine, Biomedicum, 00290 Helsinki, Finland.
    Massachusetts Institute of Technology, The Broad Institute, Cambridge, Massachusetts 02142, USA.)

  • L. Carlsson

    (The Sahlgrenska Academy, 413 45 Göteborg, Sweden.)

  • P. Jacobson

    (The Sahlgrenska Academy, 413 45 Göteborg, Sweden.)

  • L. Sjöström

    (The Sahlgrenska Academy, 413 45 Göteborg, Sweden.)

  • N. Huang

    (Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.)

  • M. E. Hurles

    (Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire CB10 1SA, UK.)

  • S. O’Rahilly

    (University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)

  • I. S. Farooqi

    (University of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK.)

  • K. Männik

    (Institute of Molecular and Cell Biology, University of Tartu, 51010 Tartu, Estonia.)

  • M.-R. Jarvelin

    (Imperial College London, London W2 1PG, UK.
    National Public Health Institute, 90101 Oulu, Finland.
    Institute of Health Sciences and Biocenter Oulu, University of Oulu, 90220 Oulu, Finland.)

  • F. Pattou

    (INSERM U859, Biotherapies for Diabetes, 59045 Lille, France.
    Université Lille Nord de France, Centre Hospitalier Universitaire Lille, 59037 Lille, France.)

  • D. Meyre

    (CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)

  • A. J. Walley

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)

  • L. J. M. Coin

    (Imperial College London, London W2 1PG, UK.)

  • A. I. F. Blakemore

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.)

  • P. Froguel

    (Section of Genomic Medicine, Imperial College London, London W12 0NN, UK.
    CNRS 8090-Institute of Biology, Pasteur Institute, 59800 Lille, France.)

  • J. S. Beckmann

    (Service de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland.
    Departement de Génétique Médicale, Université de Lausanne, CH-1015 Lausanne, Switzerland.)

Abstract

Genetic link to obesity Obesity is a highly heritable disorder but the genetic associations reported to date account for only a small percentage of the inherited variation in body mass index. Two groups report deletions on chromosome16p11.2 that may explain part of the 'missing heritability' in terms of 'high-penetrance' mutations that are rare but when present are very often associated with severe obesity. This is in contrast to more common gene defects that are less closely associated with clinical symptoms. Bochukova et al. identified rare recurrent copy number variants in 300 patients with severe early-onset obesity, caused by deletions involving several genes including SH2B1, known to be involved in leptin and insulin signalling. Many of the patients also suffered neurodevelopmental disorders. Walters et al. identified deletions of at least 593 kilobases on chromosome 16p11.2 in 31 patients with a previously unrecognized type of extreme obesity. The strategy they used to identify the lesion — using small well-phenotyped cohorts of extreme phenotypes with targeted follow-up in genome-wide association studies and population cohorts — shows promise as a means of identifying 'missing heritability' in complex metabolic diseases more generally.

Suggested Citation

  • R. G. Walters & S. Jacquemont & A. Valsesia & A. J. de Smith & D. Martinet & J. Andersson & M. Falchi & F. Chen & J. Andrieux & S. Lobbens & B. Delobel & F. Stutzmann & J. S. El-Sayed Moustafa & J.-C., 2010. "A new highly penetrant form of obesity due to deletions on chromosome 16p11.2," Nature, Nature, vol. 463(7281), pages 671-675, February.
  • Handle: RePEc:nat:nature:v:463:y:2010:i:7281:d:10.1038_nature08727
    DOI: 10.1038/nature08727
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature08727
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature08727?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:463:y:2010:i:7281:d:10.1038_nature08727. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.